Acquired Strabismus and Diplopia as Initial Presentation Signs of Hyperthyroidism and Thyroid Eye Disease

被引:0
|
作者
Chung, Seung Min [1 ]
Kim, Won Jae [2 ,3 ]
机构
[1] Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea
[2] Yeungnam Univ, Dept Ophthalmol, Coll Med, Daegu, South Korea
[3] Yeungnam Univ Hosp, Dept Ophthalmol, 170 Hyeonchung Ro, Daegu 42415, South Korea
来源
关键词
Diplopia; Hyperthyrodism; Thyroid-associated ophthalmopathy; GRAVES ORBITOPATHY; OPHTHALMOPATHY; MANAGEMENT;
D O I
10.3341/jkos.2020.61.3.288
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: We evaluated the clinical characteristics of patients who recently acquired strabismus and diplopia as the initial presentations of hyperthyroidism and thyroid eye disease (TED). Methods: The medical records of patients with acquired strabismus and diplopia who visited our clinic for evaluation between January 2017 and December 2018 were retrospectively reviewed; patients diagnosed initially with hyperthyroidism and TED were included in this study. Results: A total of 410 patients were referred to our clinic for the evaluation and treatment of diplopia. Among these patients, 12 (2.9%, 12/410) showed acquired strabismus and diplopia as the initial presentation signs of hyperthyroidism and TED. The mean age of onset of diplopia was 54.7 years (range, 18-78 years). Nine patients (75%, 9/12) were male. Six male patients were active smokers at the initial presentation. Hypotropia was the most common type of strabismus (83.3%, 10/12). The mean angle of hypodeviation was 17.5 prism diopters (PD) (range, 4-40 PD). One patient showed exotropia with hypotropia and one patient showed esotropia with a bilateral up gaze limitation. Four male patients (all active smokers) underwent strabismus surgery, and one female patient underwent orbital decompression surgery. Conclusions: The incidence of acquired strabismus and diplopia as the initial presentation sign of hyperthyroidism was predominant in male patients. Hypotropia was the most common type of strabismus. Male patients who smoked were more likely to show progression to a severe clinical course than female patients.
引用
收藏
页码:288 / 293
页数:6
相关论文
共 50 条
  • [1] DIPLOPIA IN THYROID EYE DISEASE
    FELLS, P
    MCCARRY, B
    TRANSACTIONS OF THE OPHTHALMOLOGICAL SOCIETIES OF THE UNITED KINGDOM, 1986, 105 : 413 - 423
  • [2] Initial Postoperative Alignment in Strabismus Related to Thyroid Eye Disease
    Ha, Suk-Gyu
    Kim, Seung-Hyun
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2021, 58 (01) : 23 - 27
  • [3] Management of strabismus in thyroid eye disease
    Harrad, R.
    EYE, 2015, 29 (02) : 234 - 237
  • [4] Management of strabismus in thyroid eye disease
    R Harrad
    Eye, 2015, 29 : 234 - 237
  • [5] Strabismus associated with thyroid eye disease
    Schotthoefer, Erin O.
    Wallace, David K.
    CURRENT OPINION IN OPHTHALMOLOGY, 2007, 18 (05) : 361 - 365
  • [6] Pediatric hyperthyroidism and thyroid eye disease management
    Li, Joy
    Austin, Juliana
    Douglas, Raymond S.
    Nallasamy, Sudha
    JOURNAL OF AAPOS, 2023, 27 (03): : 123 - 128
  • [7] Smoking and Strabismus Surgery in Patients with Thyroid Eye Disease
    Rajendram, Rathie
    Bunce, Catey
    Adams, Gillian G. W.
    Dayan, Colin M.
    Rose, Geoffrey E.
    OPHTHALMOLOGY, 2011, 118 (12) : 2493 - 2497
  • [8] Nonadjustable strabismus surgery for restrictive thyroid eye disease
    Godts, D
    Evens, P
    De Wilde, F
    Smet, H
    PROGRESS IN STRABISMOLOGY, 2003, : 333 - 336
  • [9] Teprotumumab for Thyroid Eye Disease-related Strabismus
    Dallalzadeh, Liane O.
    Villatoro, George A.
    Chen, Lillian
    Sim, Myung S.
    Movaghar, Mansoor
    Robbins, Shira L.
    Karlin, Justin N.
    Khitri, Monica R.
    Velez, Federico G.
    Korn, Bobby S.
    Demer, Joseph L.
    Rootman, Daniel B.
    Granet, David B.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (04): : 434 - 439
  • [10] Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease
    Bartalena, Luigi
    Smith, Terry J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (04): : 922 - 930